VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 300 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2017. The put-call ratio across all filers is 2.07 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,563,000 | -88.1% | 147,008 | -89.8% | 0.03% | -88.5% |
| Q4 2017 | $29,953,000 | +242.7% | 1,441,437 | +136.3% | 0.28% | +262.3% |
| Q3 2017 | $8,740,000 | +1555.3% | 609,944 | +1897.7% | 0.08% | +1440.0% |
| Q2 2017 | $528,000 | -79.1% | 30,532 | -86.7% | 0.01% | -77.3% |
| Q1 2017 | $2,529,000 | +606.4% | 229,275 | +1471.8% | 0.02% | +450.0% |
| Q3 2016 | $358,000 | -18.1% | 14,587 | -32.7% | 0.00% | +33.3% |
| Q2 2016 | $437,000 | -94.3% | 21,687 | -92.5% | 0.00% | -94.5% |
| Q1 2016 | $7,620,000 | +101.5% | 289,749 | +679.0% | 0.06% | +103.7% |
| Q4 2015 | $3,781,000 | -15.3% | 37,195 | +48.7% | 0.03% | 0.0% |
| Q3 2015 | $4,462,000 | +105.0% | 25,013 | +155.2% | 0.03% | +92.9% |
| Q2 2015 | $2,177,000 | +5.1% | 9,800 | -6.0% | 0.01% | +16.7% |
| Q1 2015 | $2,071,000 | +66.7% | 10,426 | +20.2% | 0.01% | +100.0% |
| Q4 2014 | $1,242,000 | -93.7% | 8,676 | -94.2% | 0.01% | -94.8% |
| Q3 2014 | $19,568,000 | +4010.9% | 149,148 | +3849.9% | 0.12% | +3733.3% |
| Q2 2014 | $476,000 | +168.9% | 3,776 | +180.7% | 0.00% | +200.0% |
| Q1 2014 | $177,000 | -35.6% | 1,345 | -42.6% | 0.00% | 0.0% |
| Q4 2013 | $275,000 | -3.8% | 2,345 | -29.5% | 0.00% | 0.0% |
| Q2 2013 | $286,000 | – | 3,328 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |